InDevR

Boulder, United States

InDevR develops and manufactures microarray technologies as well as novel solutions to support the life science industry.

$9.0M raised

Jan 2023

Series B

Biotechnology Health Care Life Science Manufacturing

Top Investors

Adjuvant CapitalNational Institute of Allergy and Infectious DiseasesbioMerieuxColorado Office of Economic Development and International Trade

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about InDevR

How much funding has InDevR raised?

InDevR has raised $9.0M in total funding. The most recent round was Series B. The last funding was announced in January 2023.

Who are InDevR's investors?

InDevR's investors include Adjuvant Capital, National Institute of Allergy and Infectious Diseases, bioMerieux, Colorado Office of Economic Development and International Trade.

Where is InDevR headquartered?

InDevR is headquartered in Boulder, United States.

What does InDevR do?

InDevR develops and manufactures microarray technologies as well as novel solutions to support the life science industry.

What stage is InDevR at?

InDevR is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 17, 2023.

MLA

"InDevR — Funding & Investors." VCBacked, January 17, 2023, https://www.vcbacked.co/company/indevr. Accessed June 3, 2026.

APA

VCBacked. (2023). InDevR — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/indevr

Wikipedia (cite web)

{{cite web |title=InDevR — Funding & Investors |url=https://www.vcbacked.co/company/indevr |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 17, 2023.

Similar Companies in Biotechnology